|
1
|
World Cancer Research Fund International:
Worldwide data. <http://www.wcrf.Org/int/cancer-facts-figures/worldwide-data>.
2012
|
|
2
|
Reddy BS and Cohen LA: Diet and colon
cancer: evidence from human and animal model studies. CRC Press;
Boca Raton, FL: pp. 47–65. 1986
|
|
3
|
Cragg GM and Newman DJ: Plants as a source
of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Potter JD: Cancer prevention: Epidemiology
and experiment. Cancer Lett. 114:7–9. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Potter JD and Steinmetz K: Vegetables,
fruit and phytoestrogens as preventive agents. IARC Sci Publ.
139:61–90. 1996.
|
|
6
|
Girish C and Pradhan SC: Drug development
for liver diseases: Focus on picroliv, ellagic acid and curcumin.
Fundam Clin Pharmacol. 22:623–632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heber D: Multitargeted therapy of cancer
by ellagitannins. Cancer Lett. 269:262–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang T, Chen HS, Wang LF, Bai MH, Wang
YC, Jiang XF and Liu M: Ellagic acid exerts anti-proliferation
effects via modulation of Tgf-β/Smad3 signaling in MCF-7 breast
cancer cells. Asian Pac J Cancer Prev. 15:273–276. 2014. View Article : Google Scholar
|
|
9
|
Dai Z, Nair V, Khan M and Ciolino HP:
Pomegranate extract inhibits the proliferation and viability of
MMTV-Wnt-1 mouse mammary cancer stem cells in vitro. Oncol Rep.
24:1087–1091. 2010.PubMed/NCBI
|
|
10
|
Wang N, Wang ZY, Mo SL, Loo TY, Wang DM,
Luo HB, Yang DP, Chen YL, Shen JG and Chen JP: Ellagic acid, a
phenolic compound, exerts anti-angiogenesis effects via VEGFR-2
signaling pathway in breast cancer. Breast Cancer Res Treat.
134:943–955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pitchakarn P, Chewonarin T, Ogawa K,
Suzuki S, Asamoto M, Takahashi S, Shirai T and Limtrakul P: Ellagic
acid inhibits migration and invasion by prostate cancer cell lines.
Asian Pac J Cancer Prev. 14:2859–2863. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT
and Pang JH: Phyllanthus urinaria increases apoptosis and reduces
telomerase activity in human nasopharyngeal carcinoma cells. Forsch
Komplement Med. 16:34–40. 2009. View Article : Google Scholar
|
|
13
|
Chen HS, Bai MH, Zhang T, Li GD and Liu M:
Ellagic acid induces cell cycle arrest and apoptosis through
TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
Int J Oncol. 46:1730–1738. 2015.PubMed/NCBI
|
|
14
|
Wright GW and Simon RM: A random variance
model for detection of differential gene expression in small
microarray experiments. Bioinformatics. 19:2448–2455. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang H, Crawford N, Lukes L, Finney R,
Lancaster M and Hunter KW: Metastasis predictive signature profiles
pre-exist in normal tissues. Clin Exp Metastasis. 22:593–603. 2005.
View Article : Google Scholar
|
|
16
|
Clarke R, Ressom HW, Wang A, Xuan J, Liu
MC, Gehan EA and Wang Y: The properties of high-dimensional data
spaces: Implications for exploring gene and protein expression
data. Nat Rev Cancer. 8:37–49. 2008. View
Article : Google Scholar :
|
|
17
|
Gene Ontology Consortium: The Gene
Ontology (GO) project in 2006. Nucleic Acids Res. 34:D322–D326.
2006. View Article : Google Scholar :
|
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dupuy D, Bertin N, Hidalgo CA, Venkatesan
K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, et al:
Genome-scale analysis of in vivo spatiotemporal promoter activity
in Caenorhabditis elegans. Nat Biotechnol. 25:663–668. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schlitt T, Palin K, Rung J, Dietmann S,
Lappe M, Ukkonen E and Brazma A: From gene networks to gene
function. Genome Res. 13:2568–2576. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32:D277–D280. 2004. View Article : Google Scholar :
|
|
22
|
Yi M, Horton JD, Cohen JC, Hobbs HH and
Stephens RM: WholePathwayScope: A comprehensive pathway-based
analysis tool for high-throughput data. BMC Bioinformatics.
7:302006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Draghici S, Khatri P, Tarca AL, Amin K,
Done A, Voichita C, Georgescu C and Romero R: A systems biology
approach for pathway level analysis. Genome Res. 17:1537–1545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jansen R, Greenbaum D and Gerstein M:
Relating whole-genome expression data with protein-protein
interactions. Genome Res. 12:37–46. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li C and Li H: Network-constrained
regularization and variable selection for analysis of genomic data.
Bioinformatics. 24:1175–1182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei Z and Li H: A Markov random field
model for network-based analysis of genomic data. Bioinformatics.
23:1537–1544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang JD and Wiemann S: KEGGgraph: A graph
approach to KEGG PATHWAY in R and bioconductor. Bioinformatics.
25:1470–1471. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Spirin V and Mirny LA: Protein complexes
and functional modules in molecular networks. Proc Natl Acad Sci
USA. 100:12123–12128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rudolf E, Andelová H and Cervinka M:
Polyphenolic compounds in chemoprevention of colon cancer - targets
and signaling pathways. Anticancer Agents Med Chem. 7:559–575.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Whitley AC, Stoner GD, Darby MV and Walle
T: Intestinal epithelial cell accumulation of the cancer preventive
polyphenol ellagic acid - extensive binding to protein and DNA.
Biochem Pharmacol. 66:907–915. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Losso JN, Bansode RR, Trappey A II, Bawadi
HA and Truax R: In vitro anti-proliferative activities of ellagic
acid. J Nutr Biochem. 15:672–678. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cho H, Jung H, Lee H, Yi HC, Kwak HK and
Hwang KT: Chemopreventive activity of ellagitannins and their
derivatives from black raspberry seeds on HT-29 colon cancer cells.
Food Funct. 6:1675–1683. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mertens-Talcott SU, Lee JH, Percival SS
and Talcott ST: Induction of cell death in Caco-2 human colon
carcinoma cells by ellagic acid rich fractions from muscadine
grapes (Vitis rotundifolia). J Agric Food Chem. 54:5336–5343. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Umesalma S and Sudhandiran G: Differential
inhibitory effects of the polyphenol ellagic acid on inflammatory
mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in
1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin
Pharmacol Toxicol. 107:650–655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kong X, Ding X and Yang Q: Identification
of multi-target effects of Huaier aqueous extract via microarray
profiling in triple-negative breast cancer cells. Int J Oncol.
46:2047–2056. 2015.PubMed/NCBI
|
|
36
|
Seeram NP, Adams LS, Henning SM, Niu Y,
Zhang Y, Nair MG and Heber D: In vitro antiproliferative, apoptotic
and antioxidant activities of punicalagin, ellagic acid and a total
pomegranate tannin extract are enhanced in combination with other
polyphenols as found in pomegranate juice. J Nutr Biochem.
16:360–367. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kang K, Oh SH, Yun JH, Jho EH, Kang JH,
Batsuren D, Tunsag J, Park KH, Kim M and Nho CW: A novel
topoisomerase inhibitor, daurinol, suppresses growth of HCT116
cells with low hematological toxicity compared to etoposide.
Neoplasia. 13:1043–1057. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
González-Sarrías A, Espín JC,
Tomás-Barberán FA and García-Conesa MT: Gene expression, cell cycle
arrest and MAPK signalling regulation in Caco-2 cells exposed to
ellagic acid and its metabolites, urolithins. Mol Nutr Food Res.
53:686–698. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ross PL, Cheng I, Liu X, Cicek MS, Carroll
PR, Casey G and Witte JS: Carboxypeptidase 4 gene variants and
early-onset intermediate-to-high risk prostate cancer. BMC Cancer.
9:692009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kung PP, Martinez R, Zhu Z, Zager M,
Blasina A, Rymer I, Hallin J, Xu M, Carroll C, Chionis J, et al:
Chemogenetic evaluation of the mitotic kinesin CENP-E reveals a
critical role in triple-negative breast cancer. Mol Cancer Ther.
13:2104–2115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ihmels J, Friedlander G, Bergmann S, Sarig
O, Ziv Y and Barkai N: Revealing modular organization in the yeast
transcriptional network. Nat Genet. 31:370–377. 2002.PubMed/NCBI
|
|
42
|
Umesalma S, Nagendraprabhu P and
Sudhandiran G: Ellagic acid inhibits proliferation and induced
apoptosis via the Akt signaling pathway in HCT-15 colon
adenocarcinoma cells. Mol Cell Biochem. 399:303–313. 2015.
View Article : Google Scholar
|
|
43
|
Viallard JF, Lacombe F, Belloc F,
Pellegrin JL and Reiffers J: Molecular mechanisms controlling the
cell cycle: Fundamental aspects and implications for oncology.
Cancer Radiother. 5:109–129. 2001.In French. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Billottet C, Quemener C and Bikfalvi A:
CXCR3, a double-edged sword in tumor progression and angiogenesis.
Biochim Biophys Acta. 1836:287–295. 2013.PubMed/NCBI
|
|
45
|
Larrosa M, Tomás-Barberán FA and Espín JC:
The dietary hydrolysable tannin punicalagin releases ellagic acid
that induces apoptosis in human colon adenocarcinoma Caco-2 cells
by using the mitochondrial pathway. J Nutr Biochem. 17:611–625.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Qiu Z, Zhou B, Jin L, Yu H, Liu L, Liu Y,
Qin C, Xie S and Zhu F: In vitro antioxidant and antiproliferative
effects of ellagic acid and its colonic metabolite, urolithins, on
human bladder cancer T24 cells. Food Chem Toxicol. 59:428–437.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mishra S and Vinayak M: Ellagic acid
checks lymphoma promotion via regulation of PKC signaling pathway.
Mol Biol Rep. 40:1417–1428. 2013. View Article : Google Scholar
|
|
48
|
Zhao M, Tang SN, Marsh JL, Shankar S and
Srivastava RK: Ellagic acid inhibits human pancreatic cancer growth
in Balb c nude mice. Cancer Lett. 337:210–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mishra S and Vinayak M: Ellagic acid
induces novel and atypical PKC isoforms and promotes caspase-3
dependent apoptosis by blocking energy metabolism. Nutr Cancer.
66:675–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Han DH, Lee MJ and Kim JH: Antioxidant and
apoptosis-inducing activities of ellagic acid. Anticancer Res.
26(5A): 3601–3606. 2006.PubMed/NCBI
|
